| Product Name | CasNo | Molecular Formula | Purity | Inquiry |
|---|---|---|---|---|
| Enasidenib | 1446502-11-9 | C19H17F6N7O | 99% | Inquiry |
| Larotrectinib Sulfate | 1223405-08-0 | C21H24F2N6O6S | 99% | Inquiry |
| Ropotrectinib | 1802220-02-5 | C18H18FN5O2 | 99% | Inquiry |
| Brigatinib | 1197953-54-0 | C29H39ClN7O2P | 99% | Inquiry |
| Crenolanib | 670220-88-9 | C26H29N5O2 | 99% | Inquiry |
| Pacritinib | 937272-79-2 | C28H32N4O3 | 99% | Inquiry |
| Remibrutinib | 1787294-07-8 | C27H27F2N5O3 | 99% | Inquiry |
| Lusutrombopag | 1110768-00-7 | C31H36Cl2N2O5S | 99% | Inquiry |
| Elobixibat | 439087-18-0 | C36H45N3O7S2 | 99% | Inquiry |
| Ripretinib | 1442472-39-0 | C24H21BrFN5O2 | 99% | Inquiry |
| Thiotepa | 52-24-4 | C6H12N3PS | 99% | Inquiry |
| Amifostine | 20537-88-6 | C5H15N2O3PS | 99% | Inquiry |
Product Name：Larotrectinib Sulfate
CasNo：1223405-08-0
Molecular Formula：C21H24F2N6O6S
Purity：99%
Inquiry
All chemicals are for R&D use only. Controlled products will be followed China law and buyer's country regulation.
